SCHEMBL22633784

SCHEMBL22633784

OC1(c2ccccc2)c2ccc(Br)cc2-c2cc(Br)ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PDK2 Q15119 2/20 0.41
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
P2RX1 P51575 1/20 0.38
P2RX3 P56373 1/20 0.38
P2RX4 Q99571 1/20 0.38
P2RX7 Q99572 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB2 P47870 1/20 0.38
PTPRC P08575 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PIM1 P11309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL824255 0.86 MEN1 (0.46) MEN1KMT2APDK2OPRM1OPRD1
SCHEMBL4585510 0.86 MEN1 (0.46) MEN1KMT2APDK2OPRM1OPRD1
SCHEMBL29948098 0.85 PDK2 (0.45) MEN1KMT2APDK2OPRM1OPRD1
SCHEMBL3038890 0.85 PDK2 (0.53) MEN1KMT2APDK2OPRM1OPRD1
SCHEMBL390934 0.85 PDK2 (0.45) MEN1KMT2APDK2OPRM1OPRD1
SCHEMBL31483494 0.85 PDK2 (0.53) MEN1KMT2APDK2OPRM1OPRD1
SCHEMBL824239 0.84 PDK2 (0.57) MEN1KMT2APDK2OPRM1OPRD1
SCHEMBL19759995 0.81 PDK2 (0.43) MEN1KMT2APDK2OPRM1OPRD1
SCHEMBL18032791 0.80 KDM4E (0.44) MEN1KMT2APDK2OPRM1OPRD1
SCHEMBL13819624 0.78 PDK2 (0.41) MEN1KMT2APDK2OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718580-B2 Fluorene derivatized monomers and polymers for volume Bragg gratings META PLATFORMS TECHNOLOGIES, LLC (US) 2023-08-08 US disclosed
US-11718580-B2 Fluorene derivatized monomers and polymers for volume Bragg gratings META PLATFORMS TECHNOLOGIES, LLC (US) 2023-08-08 US disclosed
US-11718580-B2 Fluorene derivatized monomers and polymers for volume Bragg gratings META PLATFORMS TECHNOLOGIES, LLC (US) 2023-08-08 US disclosed
EP-3966195-B1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS FACEBOOK TECH LLC (US) 2023-07-05 EP disclosed
EP-3966195-B1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS FACEBOOK TECH LLC (US) 2023-07-05 EP disclosed
EP-3966195-A1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS Facebook Technologies, LLC (US) 2022-03-16 EP disclosed
CN-113784946-A Fluorene derived monomers and polymers for volume bragg gratings 脸谱科技有限责任公司 2021-12-10 CN disclosed
US-20200354311-A1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS META PLATFORMS TECHNOLOGIES, LLC 2020-11-12 US disclosed
WO-2020227264-A1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS FACEBOOK TECHNOLOGIES, LLC (US) 2020-11-12 WO disclosed
WO-2020227264-A1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS FACEBOOK TECHNOLOGIES, LLC (US) 2020-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200354311-A1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS RHOA, PARG, LSG1 MEN1 309/4885KMT2A 547/4885PDK2 4171/4885
US-11718580-B2 Fluorene derivatized monomers and polymers for volume Bragg gratings RHOA, PARG, LSG1 MEN1 309/4885KMT2A 547/4885PDK2 4171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.